Last $5.33 USD
Change Today -0.12 / -2.20%
Volume 308.2K
NEO On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

neogenomics inc (NEO) Snapshot

Open
$5.45
Previous Close
$5.45
Day High
$5.49
Day Low
$5.29
52 Week High
07/18/14 - $5.77
52 Week Low
08/30/13 - $2.15
Market Cap
303.8M
Average Volume 10 Days
325.9K
EPS TTM
$0.05
Shares Outstanding
57.0M
EX-Date
--
P/E TM
102.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOGENOMICS INC (NEO)

Related News

No related news articles were found.

neogenomics inc (NEO) Related Businessweek News

No Related Businessweek News Found

neogenomics inc (NEO) Details

NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

neogenomics inc (NEO) Top Compensated Officers

Executive Chairman and Chief Executive Office...
Total Annual Compensation: $557.0K
Chief Financial Officer
Total Annual Compensation: $305.5K
Chief Medical Officer and Director of Researc...
Total Annual Compensation: $92.5K
Chief Compliance Officer, Executive Vice Pres...
Total Annual Compensation: $72.5K
Compensation as of Fiscal Year 2013.

neogenomics inc (NEO) Key Developments

Neogenomics Mulls Acquisitions With $32 Million

Neogenomics Inc. (NasdaqCM:NEO) intends to pursue acquisitions. The company has priced an underwritten public offering of 7 million shares for gross proceeds of $32.2 million. The Company plans to use the net proceeds for working capital, capital expenditures and for general corporate purposes, including potential acquisitions and the repayment of debt.

Neogenomics Mulls Acquisitions

Neogenomics Inc. (NasdaqCM:NEO) is seeking acquisition opportunities. Neogenomics announced that it has commenced an underwritten public offering of shares of its common stock. NeoGenomics anticipates using the net proceeds from the offering for working capital, capital expenditures and other corporate purposes, including potential acquisitions and the repayment of debt.

Neogenomics Announces Resignation of Robert Gasparini as Chief Scientific Officer

On August 4, 2014 Neogenomics Inc. announced that Robert Gasparini, Chief Scientific Officer retired and resigned his officer position. Mr. Gasparini has agreed to continue to serve as a consultant to NeoGenomics Laboratories Inc. on a part-time basis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.33 USD -0.12

NEO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEO.
View Industry Companies
 

Industry Analysis

NEO

Industry Average

Valuation NEO Industry Range
No financial data is available for NEO.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit www.neogenomics.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.